Alexion Beats Trade Secret Claims In Amyndas Suit
By Adam Lidgett · April 2, 2026, 6:17 PM EDT
Amyndas Pharmaceuticals failed to specifically identify the trade secrets it claimed pharmaceutical company Alexion learned of during early partnership talks and improperly used to launch a business collaboration with another competitor,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login